These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26239995)

  • 1. In Vitro Activities of Eight Antifungal Drugs against a Global Collection of Genotyped Exserohilum Isolates.
    Chowdhary A; Hagen F; Curfs-Breuker I; Madrid H; de Hoog GS; Meis JF
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6642-5. PubMed ID: 26239995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro Susceptibility Profiles of Eight Antifungal Drugs against Clinical and Environmental Strains of Phaeoacremonium.
    Badali H; Khodavaisy S; Fakhim H; de Hoog GS; Meis JF; Chowdhary A
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7818-22. PubMed ID: 26369976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activities of eight antifungal drugs against 106 waterborne and cutaneous exophiala species.
    Najafzadeh MJ; Saradeghi Keisari M; Vicente VA; Feng P; Shamsian SA; Rezaei-Matehkolaei A; de Hoog GS; Curfs-Breuker I; Meis JF
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6395-8. PubMed ID: 24100491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro antifungal susceptibility of Cladophialophora carrionii, an agent of human chromoblastomycosis.
    Deng S; de Hoog GS; Badali H; Yang L; Najafzadeh MJ; Pan B; Curfs-Breuker I; Meis JF; Liao W
    Antimicrob Agents Chemother; 2013 Apr; 57(4):1974-7. PubMed ID: 23380718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activities of nine antifungal drugs against 81 Phialophora and Cyphellophora isolates.
    Feng P; Najafzadeh MJ; Sun J; Ahmed S; Xi L; de Hoog GS; Lai W; Lu C; Klaassen CH; Meis JF
    Antimicrob Agents Chemother; 2012 Nov; 56(11):6044-7. PubMed ID: 22948876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp.
    Najafzadeh MJ; Badali H; Illnait-Zaragozi MT; De Hoog GS; Meis JF
    Antimicrob Agents Chemother; 2010 Apr; 54(4):1636-8. PubMed ID: 20086140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species.
    Skóra M; Bulanda M; Jagielski T
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5827-9. PubMed ID: 26100698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates.
    Hagen F; Illnait-Zaragozi MT; Bartlett KH; Swinne D; Geertsen E; Klaassen CH; Boekhout T; Meis JF
    Antimicrob Agents Chemother; 2010 Dec; 54(12):5139-45. PubMed ID: 20855729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species.
    Lackner M; de Hoog GS; Verweij PE; Najafzadeh MJ; Curfs-Breuker I; Klaassen CH; Meis JF
    Antimicrob Agents Chemother; 2012 May; 56(5):2635-42. PubMed ID: 22290955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Head-to-head comparison of inhibitory and fungicidal activities of fluconazole, itraconazole, voriconazole, posaconazole, and isavuconazole against clinical isolates of Trichosporon asahii.
    Hazirolan G; Canton E; Sahin S; Arikan-Akdagli S
    Antimicrob Agents Chemother; 2013 Oct; 57(10):4841-7. PubMed ID: 23877683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro susceptibility patterns of clinically important Trichophyton and Epidermophyton species against nine antifungal drugs.
    Badali H; Mohammadi R; Mashedi O; de Hoog GS; Meis JF
    Mycoses; 2015 May; 58(5):303-7. PubMed ID: 25757042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large-Scale Evaluation of
    Thompson GR; Barker BM; Wiederhold NP
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28096163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility testing of Aspergillus spp. against voriconazole, itraconazole, posaconazole, amphotericin B and caspofungin.
    Shi JY; Xu YC; Shi Y; Lü HX; Liu Y; Zhao WS; Chen DM; Xi LY; Zhou X; Wang H; Guo LN
    Chin Med J (Engl); 2010 Oct; 123(19):2706-9. PubMed ID: 21034656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility profile of echinocandins, azoles and amphotericin B against yeast phase of Talaromyces marneffei isolated from HIV-infected patients in Guangdong, China.
    Lei HL; Li LH; Chen WS; Song WN; He Y; Hu FY; Chen XJ; Cai WP; Tang XP
    Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1099-1102. PubMed ID: 29536323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Activities of Five Antifungal Drugs Against Opportunistic Agents of Aspergillus Nigri Complex.
    Badali H; Fakhim H; Zarei F; Nabili M; Vaezi A; Poorzad N; Dolatabadi S; Mirhendi H
    Mycopathologia; 2016 Apr; 181(3-4):235-40. PubMed ID: 26615417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates.
    Mario DA; Denardi LB; Bandeira LA; Antunes MS; Santurio JM; Severo LC; Alves SH
    Mem Inst Oswaldo Cruz; 2012 May; 107(3):433-6. PubMed ID: 22510843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.
    Pfaller MA; Messer SA; Rhomberg PR; Castanheira M
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values.
    Pfaller MA; Rhomberg PR; Messer SA; Jones RN; Castanheira M
    Diagn Microbiol Infect Dis; 2015 Aug; 82(4):303-13. PubMed ID: 25986029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activities of E1210 and comparator agents tested by CLSI and EUCAST broth microdilution methods against Fusarium and Scedosporium species identified using molecular methods.
    Castanheira M; Duncanson FP; Diekema DJ; Guarro J; Jones RN; Pfaller MA
    Antimicrob Agents Chemother; 2012 Jan; 56(1):352-7. PubMed ID: 22083469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of antifungal susceptibility and clinical characteristics in fungal keratitis in a tertiary care center in North India.
    Vanathi M; Naik R; Sidhu N; Ahmed NH; Gupta N; Tandon R
    Indian J Ophthalmol; 2022 Dec; 70(12):4270-4283. PubMed ID: 36453329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.